View Future GrowthChemring Group 過去の業績過去 基準チェック /56Chemring Groupは、平均年間3.7%の収益成長を遂げていますが、 Aerospace & Defense業界の収益は、年間 成長しています。収益は、平均年間20.1% 6%収益成長率で 成長しています。 Chemring Groupの自己資本利益率は14%であり、純利益率は10.7%です。主要情報3.75%収益成長率4.68%EPS成長率Aerospace & Defense 業界の成長5.38%収益成長率5.98%株主資本利益率13.95%ネット・マージン10.71%前回の決算情報31 Oct 2025最近の業績更新お知らせ • Oct 07Chemring Group PLC to Report Fiscal Year 2025 Results on Dec 09, 2025Chemring Group PLC announced that they will report fiscal year 2025 results on Dec 09, 2025お知らせ • Feb 26Chemring Group PLC to Report First Half, 2025 Results on Jun 03, 2025Chemring Group PLC announced that they will report first half, 2025 results on Jun 03, 2025お知らせ • Oct 17Chemring Group PLC to Report Fiscal Year 2024 Results on Dec 17, 2024Chemring Group PLC announced that they will report fiscal year 2024 results on Dec 17, 2024お知らせ • Jan 10Chemring Group PLC to Report First Half, 2024 Results on Jun 04, 2024Chemring Group PLC announced that they will report first half, 2024 results on Jun 04, 2024お知らせ • Aug 09+ 2 more updatesChemring Group PLC to Report Q4, 2023 Results on Dec 12, 2023Chemring Group PLC announced that they will report Q4, 2023 results on Dec 12, 2023お知らせ • Feb 01Chemring Group PLC to Report Q2, 2023 Results on Jun 06, 2023Chemring Group PLC announced that they will report Q2, 2023 results on Jun 06, 2023すべての更新を表示Recent updatesお知らせ • Mar 05Chemring Group plc Announces Appointment of Baroness Kate Rock as Independent Non-Executive Director, Member of the Audit, Nomination and Remuneration Committees, Effective April 1, 2026Chemring Group PLC announced the appointment of Baroness Kate Rock as an independent non-executive director. Upon joining the Board, Kate will become the Senior Independent Director and a member of the Audit, Nomination and Remuneration Committees. She will join the Board with effect from April 1, 2026. Kate is an experienced non-executive director with a board portfolio covering technology, engineering, construction and infrastructure. Underpinned by a strong background in corporate communications and strategy, she combines deep engineering sector knowledge with a strategic understanding of how innovation and technology enhance productivity, together with wide-ranging experience working across government. On December 1, 2022, Kate was appointed Non-Executive Chair of the UK infrastructure solutions company Costain Group PLC. Since that time Costain has seen a near five-fold increase in its share price and has re-entered the FTSE 250 index. In September 2018, she joined the Board of FTSE 250 Keller Group plc (the world's largest geotechnical specialist contractor) and is now the Senior Independent Director, serving on the Audit & Risk, Nomination & Governance, Remuneration and Sustainability Committees. Having been appointed a Life Peer in 2015, she sat on the House of Lords Science and Technology Select Committee until January 2023. She was also a member of the House of Lords Select Committee on Artificial Intelligence from 2017 to 2018 and was Chair of the House of Lords Select Committee on Autism between January and November 2025. Until January 2023, Kate was a Board member of the world's first Centre for Data Ethics and Innovation and was, until November 2017, a non-executive director of Imagination Technologies plc, the former global FTSE 250 high technology company.お知らせ • Feb 20Chemring Group PLC Appoints Stephen King as Interim Senior Independent DirectorChemring Group PLC announced that as previously announced, Fiona MacAulay, Senior Independent Director, will not be seeking re-election at today's Annual General Meeting. The process to identify a suitable candidate to replace her is progressing well. In the meantime, Stephen King, Non-Executive Director, has been appointed the Interim Senior Independent Director. Stephen will fulfil this role in addition to his role as Chair of the Audit Committee.お知らせ • Dec 10Chemring Group PLC, Annual General Meeting, Feb 20, 2026Chemring Group PLC, Annual General Meeting, Feb 20, 2026.お知らせ • Nov 10Fiona Macaulay Not Stand for Re-Election to the Board of Chemring Group plcChemring Group PLC announced Fiona MacAulay, Senior Independent Director, has informed the Board that she will not be seeking re-election at the Group's Annual General Meeting in February 2026. Fiona's second three-year term as a non-executive director would otherwise have expired on 2 June 2026. The Chairman and the Board of Directors wish to extend their due to Fiona for her considerable contribution to the Group. A process to identify a suitable candidate to replace her will now be instigated.お知らせ • Oct 07Chemring Group PLC to Report Fiscal Year 2025 Results on Dec 09, 2025Chemring Group PLC announced that they will report fiscal year 2025 results on Dec 09, 2025お知らせ • Jun 30Chemring Group PLC (LSE:CHG) agreed to acquire Landguard Nexus Limited for £20 million.Chemring Group PLC (LSE:CHG) agreed to acquire Landguard Nexus Limited for £20 million on June 30, 2025. The consideration will be satisfied by a £14 million cash payment on completion, funded from Chemring's existing bank facilities, and cash earnouts totaling up to £6 million subject to certain performance targets. The acquisition is expected to be marginally earnings enhancing in the year ending October 31, 2026. Following completion of the acquisition, the current owner-managers of Landguard are expected to remain with Chemring. For the period ending January 31, 2025, Landguard Nexus Limited reported total revenue of £7 million. Completion of the transaction is subject to approval under the UK National Investment and Security Act.お知らせ • Jun 03Chemring Group plc Announces Interim Dividend, Payable on September 5, 2025Chemring Group PLC has declared an interim dividend in respect of the 2025 financial year of 2.7 pence (first half of 2024: 2.6 pence) per ordinary share which will be paid on 5 September 2025 to shareholders on the register on 15 August 2025.お知らせ • Feb 26Chemring Group PLC to Report First Half, 2025 Results on Jun 03, 2025Chemring Group PLC announced that they will report first half, 2025 results on Jun 03, 2025お知らせ • Dec 20Chemring Group PLC, Annual General Meeting, Feb 26, 2025Chemring Group PLC, Annual General Meeting, Feb 26, 2025.お知らせ • Dec 17Chemring Group PLC Recommends Final Dividend for the Year Ended 31 October, 2024, Payable on 11 April 2025The Board of Chemring Group PLC is recommending a final dividend in respect of the year to 31 October 2024 of 5.2 pence (2023: 4.6 pence) per ordinary share. The estimated cash value of this dividend is £14.5 million. With the interim dividend of 2.6 pence per share (2023: 2.3 pence), this results in a total dividend of 7.8 pence (2023: 6.9 pence) per ordinary share. If approved, the final dividend will be paid on 11 April 2025 to shareholders on the register on 21 March 2025. In accordance with accounting standards, this final dividend has not been recorded as a liability as at 31 October 2024.お知らせ • Dec 05Chemring Group Announces Board ChangesChemring announced that Andrew Davies, who has been a non-executive director since May 2016 and the Senior Independent Director since May 2020, will retire from the Board on 31 January 2025, having approached the end of his nine-year term, and will not therefore seek re-election at the 2025 Annual General Meeting. As previously indicated in the 2023 annual report, Fiona MacAulay, who has been a non-executive director since June 2020, will succeed Andrew as the Senior Independent Director.お知らせ • Oct 17Chemring Group PLC to Report Fiscal Year 2024 Results on Dec 17, 2024Chemring Group PLC announced that they will report fiscal year 2024 results on Dec 17, 2024お知らせ • Jun 24Chemring Group plc Announces Board ChangesChemring Group PLC announced the appointment of Tony Wood as an independent non-executive director and Chairman-designate. He joins the Board with effect from October 1, 2024 and will succeed Carl-Peter Forster as Chairman of the Board on 1 December 2024, following Carl-Peter's retirement on November 30, 2024. Carl-Peter joined the Board of Chemring on 1 May 2016 and was appointed Chairman on July 1, 2016. Since then he has successfully led the Group through a period of significant transformation as they have built a stronger, higher-quality and more resilient business. The investments made in both culture and infrastructure position the Group well to capitalise on its many opportunities. Tony is a member of the Board of Directors of Airbus SE, the CAC 40 aerospace and defence firm, and National Grid plc, an energy company operating in the UK and the US. From 2018-2022 he was Chief Executive of FTSE 100 Meggitt plc, where he led the operational and cultural transformation of the company. He brings to the Board significant engineering and sector experience having also been a Non-Executive Director and former President of ADS Group Limited, the trade association for the Aerospace, Defence, Security and Space sectors in the UK, from 2020-2023. Prior to joining Meggitt he spent 15 years at Rolls-Royce plc, latterly serving as President of Aerospace from 2013-2016. Tony holds a degree in Engineering from the Open University in the UK and a Master of Business Administration from INSEAD in France. He is a Fellow of the Royal Aeronautical Society and a Fellow of the Association for Project Management.お知らせ • Jan 10Chemring Group PLC to Report First Half, 2024 Results on Jun 04, 2024Chemring Group PLC announced that they will report first half, 2024 results on Jun 04, 2024お知らせ • Dec 12+ 2 more updatesChemring Group PLC, Annual General Meeting, Feb 23, 2024Chemring Group PLC, Annual General Meeting, Feb 23, 2024.お知らせ • Sep 12Chemring Group PLC Provides Revenue Guidance for the Year Ending 31 October 2023Chemring Group PLC provided revenue guidance for the year ending 31 October 2023. Expected fiscal year 2023 revenue is now fully covered by the order book and the outturn for the year ending 31 October 2023 remains in line with the Board's and current analyst expectations. Achieving full year expectations is subject to US Department of Defense ("US DoD") approval of certain countermeasure deliveries, representing c.£25m of revenue, that have already been manufactured and will be recognised once approval is received.お知らせ • Aug 09+ 2 more updatesChemring Group PLC to Report Q4, 2023 Results on Dec 12, 2023Chemring Group PLC announced that they will report Q4, 2023 results on Dec 12, 2023お知らせ • Jun 13Chemring Group plc Announces Appointment of Alpna Amar as an Independent Non-Executive Director with Immediate EffectChemring Group PLC announced the appointment of Alpna Amar as an independent non-executive director. She will join the Board with immediate effect. Alpna (age 43) is currently Corporate Development Director of Kier Group plc and has been a member of Kier Group's Executive Committee since May 2021. A qualified Chartered Accountant, Alpna has over 22 years of corporate, operational and commercial finance, strategy, M&A and investor relations experience in both corporate and consulting positions. Prior to Kier Group she held senior investor relations and corporate development roles at global automotive suppliers, TI Fluid Systems plc and International Automotive Components Group SA. Alpna is a fellow of the Institute of Chartered Accountants of England and Wales and has a degree in Economics and Politics from Lancaster University. Upon joining the Board, Alpna Amar will become a member of the Audit and Nomination Committees.お知らせ • May 25Chemring Group plc Announces Appointment of James Mortensen as Chief Financial OfficerChemring Group PLC announced appointment of James Mortensen as Chief Financial Officer. James has a proven track record in industrial, engineering and technology sectors with extensive experience in building and managing global, multi-disciplinary finance teams. He joins Chemring from Smiths Group plc ("Smiths"), the FTSE 100 engineering group where he has spent the last seven years. James joined the Smiths M&A team in 2016 and, having played a key role in scaling ventilator manufacturing during COVID for the UK Government, he became Chief Financial Officer of the $1.1bn revenue Smiths Medical Division in 2020. He held this role until the sale of Smiths Medical for $2.7bn in February 2022, having also prepared the business for a London listing. He is currently Group Head of Corporate Development with responsibility for sourcing, evaluating and executing acquisitions across the four major global markets where Smiths operate: Security & Defence, Aerospace, General Industry and Energy. Prior to Smiths James spent eight years at Smith & Nephew plc, the FTSE 100 medical technology company where he held progressively senior finance roles in the areas of group reporting, strategic planning and corporate finance. Having graduated from Bristol University James started his career at KPMG in their audit practice and is a fellow of the Institute of Chartered Accountants of England and Wales. James will take over from Andrew Lewis, who announced his intention to retire on 23 January 2023 and whose notice period runs until 22 January 2024. The Group is working with James to agree the date on which he will join Chemring. A further announcement will be made in due course.お知らせ • Feb 01Chemring Group PLC to Report Q2, 2023 Results on Jun 06, 2023Chemring Group PLC announced that they will report Q2, 2023 results on Jun 06, 2023お知らせ • Jan 23+ 1 more updateChemring Group PLC Announces Retirement of Andrew Lewis as DirectorChemring Group PLC announced that After six years as a director of the Company, Andrew Lewis has informed the Board of his intention to retire. Andrew's notice period is 12 months; he will continue in role to ensure a smooth transition. The Board has commenced a search process to identify his successor.お知らせ • Dec 13Chemring Group PLC, Annual General Meeting, Mar 15, 2023Chemring Group PLC, Annual General Meeting, Mar 15, 2023.収支内訳Chemring Group の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:CMGM.F 収益、費用、利益 ( )GBP Millions日付収益収益G+A経費研究開発費31 Oct 25498532081431 Jul 25498522021430 Apr 25521511971431 Jan 25516471961431 Oct 24488421951431 Jul 24489361861230 Apr 24490311781031 Jan 24481341771031 Oct 23473381771030 Apr 23387373031 Jan 23394415031 Oct 22401447031 Jul 22429477030 Apr 22415478031 Jan 22404447031 Oct 21393425031 Jul 21402415030 Apr 21410404031 Jan 21406374031 Oct 20403354031 Jul 2039535672630 Apr 20387361305231 Jan 20361301295231 Oct 19335231295231 Jul 1931921214730 Apr 19304-181134131 Jan 19301-301144131 Oct 18297-411144131 Jul 18244-301164430 Apr 18191-201194831 Jan 18249-121184831 Oct 17307-41184831 Jul 1742761315030 Apr 17547161455131 Jan 17512111445131 Oct 1647771445131 Jul 1643601072630 Apr 16396-771031 Jan 16387-671031 Oct 15377-571031 Jul 15367-11760質の高い収益: CMGM.Fは 高品質の収益 を持っています。利益率の向上: CMGM.Fの現在の純利益率 (10.7%)は、昨年(8.5%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: CMGM.Fの収益は過去 5 年間で年間3.7%増加しました。成長の加速: CMGM.Fの過去 1 年間の収益成長率 ( 28.4% ) は、5 年間の平均 ( 年間3.7%を上回っています。収益対業界: CMGM.Fの過去 1 年間の収益成長率 ( 28.4% ) はAerospace & Defense業界23.6%を上回りました。株主資本利益率高いROE: CMGM.Fの 自己資本利益率 ( 14% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YCapital-goods 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/23 13:32終値2026/05/19 00:00収益2025/10/31年間収益2025/10/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Chemring Group PLC 7 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。18 アナリスト機関Richard PaigeBarclaysGeorge McwhirterBerenbergJamie MurrayBofA Global Research15 その他のアナリストを表示
お知らせ • Oct 07Chemring Group PLC to Report Fiscal Year 2025 Results on Dec 09, 2025Chemring Group PLC announced that they will report fiscal year 2025 results on Dec 09, 2025
お知らせ • Feb 26Chemring Group PLC to Report First Half, 2025 Results on Jun 03, 2025Chemring Group PLC announced that they will report first half, 2025 results on Jun 03, 2025
お知らせ • Oct 17Chemring Group PLC to Report Fiscal Year 2024 Results on Dec 17, 2024Chemring Group PLC announced that they will report fiscal year 2024 results on Dec 17, 2024
お知らせ • Jan 10Chemring Group PLC to Report First Half, 2024 Results on Jun 04, 2024Chemring Group PLC announced that they will report first half, 2024 results on Jun 04, 2024
お知らせ • Aug 09+ 2 more updatesChemring Group PLC to Report Q4, 2023 Results on Dec 12, 2023Chemring Group PLC announced that they will report Q4, 2023 results on Dec 12, 2023
お知らせ • Feb 01Chemring Group PLC to Report Q2, 2023 Results on Jun 06, 2023Chemring Group PLC announced that they will report Q2, 2023 results on Jun 06, 2023
お知らせ • Mar 05Chemring Group plc Announces Appointment of Baroness Kate Rock as Independent Non-Executive Director, Member of the Audit, Nomination and Remuneration Committees, Effective April 1, 2026Chemring Group PLC announced the appointment of Baroness Kate Rock as an independent non-executive director. Upon joining the Board, Kate will become the Senior Independent Director and a member of the Audit, Nomination and Remuneration Committees. She will join the Board with effect from April 1, 2026. Kate is an experienced non-executive director with a board portfolio covering technology, engineering, construction and infrastructure. Underpinned by a strong background in corporate communications and strategy, she combines deep engineering sector knowledge with a strategic understanding of how innovation and technology enhance productivity, together with wide-ranging experience working across government. On December 1, 2022, Kate was appointed Non-Executive Chair of the UK infrastructure solutions company Costain Group PLC. Since that time Costain has seen a near five-fold increase in its share price and has re-entered the FTSE 250 index. In September 2018, she joined the Board of FTSE 250 Keller Group plc (the world's largest geotechnical specialist contractor) and is now the Senior Independent Director, serving on the Audit & Risk, Nomination & Governance, Remuneration and Sustainability Committees. Having been appointed a Life Peer in 2015, she sat on the House of Lords Science and Technology Select Committee until January 2023. She was also a member of the House of Lords Select Committee on Artificial Intelligence from 2017 to 2018 and was Chair of the House of Lords Select Committee on Autism between January and November 2025. Until January 2023, Kate was a Board member of the world's first Centre for Data Ethics and Innovation and was, until November 2017, a non-executive director of Imagination Technologies plc, the former global FTSE 250 high technology company.
お知らせ • Feb 20Chemring Group PLC Appoints Stephen King as Interim Senior Independent DirectorChemring Group PLC announced that as previously announced, Fiona MacAulay, Senior Independent Director, will not be seeking re-election at today's Annual General Meeting. The process to identify a suitable candidate to replace her is progressing well. In the meantime, Stephen King, Non-Executive Director, has been appointed the Interim Senior Independent Director. Stephen will fulfil this role in addition to his role as Chair of the Audit Committee.
お知らせ • Dec 10Chemring Group PLC, Annual General Meeting, Feb 20, 2026Chemring Group PLC, Annual General Meeting, Feb 20, 2026.
お知らせ • Nov 10Fiona Macaulay Not Stand for Re-Election to the Board of Chemring Group plcChemring Group PLC announced Fiona MacAulay, Senior Independent Director, has informed the Board that she will not be seeking re-election at the Group's Annual General Meeting in February 2026. Fiona's second three-year term as a non-executive director would otherwise have expired on 2 June 2026. The Chairman and the Board of Directors wish to extend their due to Fiona for her considerable contribution to the Group. A process to identify a suitable candidate to replace her will now be instigated.
お知らせ • Oct 07Chemring Group PLC to Report Fiscal Year 2025 Results on Dec 09, 2025Chemring Group PLC announced that they will report fiscal year 2025 results on Dec 09, 2025
お知らせ • Jun 30Chemring Group PLC (LSE:CHG) agreed to acquire Landguard Nexus Limited for £20 million.Chemring Group PLC (LSE:CHG) agreed to acquire Landguard Nexus Limited for £20 million on June 30, 2025. The consideration will be satisfied by a £14 million cash payment on completion, funded from Chemring's existing bank facilities, and cash earnouts totaling up to £6 million subject to certain performance targets. The acquisition is expected to be marginally earnings enhancing in the year ending October 31, 2026. Following completion of the acquisition, the current owner-managers of Landguard are expected to remain with Chemring. For the period ending January 31, 2025, Landguard Nexus Limited reported total revenue of £7 million. Completion of the transaction is subject to approval under the UK National Investment and Security Act.
お知らせ • Jun 03Chemring Group plc Announces Interim Dividend, Payable on September 5, 2025Chemring Group PLC has declared an interim dividend in respect of the 2025 financial year of 2.7 pence (first half of 2024: 2.6 pence) per ordinary share which will be paid on 5 September 2025 to shareholders on the register on 15 August 2025.
お知らせ • Feb 26Chemring Group PLC to Report First Half, 2025 Results on Jun 03, 2025Chemring Group PLC announced that they will report first half, 2025 results on Jun 03, 2025
お知らせ • Dec 20Chemring Group PLC, Annual General Meeting, Feb 26, 2025Chemring Group PLC, Annual General Meeting, Feb 26, 2025.
お知らせ • Dec 17Chemring Group PLC Recommends Final Dividend for the Year Ended 31 October, 2024, Payable on 11 April 2025The Board of Chemring Group PLC is recommending a final dividend in respect of the year to 31 October 2024 of 5.2 pence (2023: 4.6 pence) per ordinary share. The estimated cash value of this dividend is £14.5 million. With the interim dividend of 2.6 pence per share (2023: 2.3 pence), this results in a total dividend of 7.8 pence (2023: 6.9 pence) per ordinary share. If approved, the final dividend will be paid on 11 April 2025 to shareholders on the register on 21 March 2025. In accordance with accounting standards, this final dividend has not been recorded as a liability as at 31 October 2024.
お知らせ • Dec 05Chemring Group Announces Board ChangesChemring announced that Andrew Davies, who has been a non-executive director since May 2016 and the Senior Independent Director since May 2020, will retire from the Board on 31 January 2025, having approached the end of his nine-year term, and will not therefore seek re-election at the 2025 Annual General Meeting. As previously indicated in the 2023 annual report, Fiona MacAulay, who has been a non-executive director since June 2020, will succeed Andrew as the Senior Independent Director.
お知らせ • Oct 17Chemring Group PLC to Report Fiscal Year 2024 Results on Dec 17, 2024Chemring Group PLC announced that they will report fiscal year 2024 results on Dec 17, 2024
お知らせ • Jun 24Chemring Group plc Announces Board ChangesChemring Group PLC announced the appointment of Tony Wood as an independent non-executive director and Chairman-designate. He joins the Board with effect from October 1, 2024 and will succeed Carl-Peter Forster as Chairman of the Board on 1 December 2024, following Carl-Peter's retirement on November 30, 2024. Carl-Peter joined the Board of Chemring on 1 May 2016 and was appointed Chairman on July 1, 2016. Since then he has successfully led the Group through a period of significant transformation as they have built a stronger, higher-quality and more resilient business. The investments made in both culture and infrastructure position the Group well to capitalise on its many opportunities. Tony is a member of the Board of Directors of Airbus SE, the CAC 40 aerospace and defence firm, and National Grid plc, an energy company operating in the UK and the US. From 2018-2022 he was Chief Executive of FTSE 100 Meggitt plc, where he led the operational and cultural transformation of the company. He brings to the Board significant engineering and sector experience having also been a Non-Executive Director and former President of ADS Group Limited, the trade association for the Aerospace, Defence, Security and Space sectors in the UK, from 2020-2023. Prior to joining Meggitt he spent 15 years at Rolls-Royce plc, latterly serving as President of Aerospace from 2013-2016. Tony holds a degree in Engineering from the Open University in the UK and a Master of Business Administration from INSEAD in France. He is a Fellow of the Royal Aeronautical Society and a Fellow of the Association for Project Management.
お知らせ • Jan 10Chemring Group PLC to Report First Half, 2024 Results on Jun 04, 2024Chemring Group PLC announced that they will report first half, 2024 results on Jun 04, 2024
お知らせ • Dec 12+ 2 more updatesChemring Group PLC, Annual General Meeting, Feb 23, 2024Chemring Group PLC, Annual General Meeting, Feb 23, 2024.
お知らせ • Sep 12Chemring Group PLC Provides Revenue Guidance for the Year Ending 31 October 2023Chemring Group PLC provided revenue guidance for the year ending 31 October 2023. Expected fiscal year 2023 revenue is now fully covered by the order book and the outturn for the year ending 31 October 2023 remains in line with the Board's and current analyst expectations. Achieving full year expectations is subject to US Department of Defense ("US DoD") approval of certain countermeasure deliveries, representing c.£25m of revenue, that have already been manufactured and will be recognised once approval is received.
お知らせ • Aug 09+ 2 more updatesChemring Group PLC to Report Q4, 2023 Results on Dec 12, 2023Chemring Group PLC announced that they will report Q4, 2023 results on Dec 12, 2023
お知らせ • Jun 13Chemring Group plc Announces Appointment of Alpna Amar as an Independent Non-Executive Director with Immediate EffectChemring Group PLC announced the appointment of Alpna Amar as an independent non-executive director. She will join the Board with immediate effect. Alpna (age 43) is currently Corporate Development Director of Kier Group plc and has been a member of Kier Group's Executive Committee since May 2021. A qualified Chartered Accountant, Alpna has over 22 years of corporate, operational and commercial finance, strategy, M&A and investor relations experience in both corporate and consulting positions. Prior to Kier Group she held senior investor relations and corporate development roles at global automotive suppliers, TI Fluid Systems plc and International Automotive Components Group SA. Alpna is a fellow of the Institute of Chartered Accountants of England and Wales and has a degree in Economics and Politics from Lancaster University. Upon joining the Board, Alpna Amar will become a member of the Audit and Nomination Committees.
お知らせ • May 25Chemring Group plc Announces Appointment of James Mortensen as Chief Financial OfficerChemring Group PLC announced appointment of James Mortensen as Chief Financial Officer. James has a proven track record in industrial, engineering and technology sectors with extensive experience in building and managing global, multi-disciplinary finance teams. He joins Chemring from Smiths Group plc ("Smiths"), the FTSE 100 engineering group where he has spent the last seven years. James joined the Smiths M&A team in 2016 and, having played a key role in scaling ventilator manufacturing during COVID for the UK Government, he became Chief Financial Officer of the $1.1bn revenue Smiths Medical Division in 2020. He held this role until the sale of Smiths Medical for $2.7bn in February 2022, having also prepared the business for a London listing. He is currently Group Head of Corporate Development with responsibility for sourcing, evaluating and executing acquisitions across the four major global markets where Smiths operate: Security & Defence, Aerospace, General Industry and Energy. Prior to Smiths James spent eight years at Smith & Nephew plc, the FTSE 100 medical technology company where he held progressively senior finance roles in the areas of group reporting, strategic planning and corporate finance. Having graduated from Bristol University James started his career at KPMG in their audit practice and is a fellow of the Institute of Chartered Accountants of England and Wales. James will take over from Andrew Lewis, who announced his intention to retire on 23 January 2023 and whose notice period runs until 22 January 2024. The Group is working with James to agree the date on which he will join Chemring. A further announcement will be made in due course.
お知らせ • Feb 01Chemring Group PLC to Report Q2, 2023 Results on Jun 06, 2023Chemring Group PLC announced that they will report Q2, 2023 results on Jun 06, 2023
お知らせ • Jan 23+ 1 more updateChemring Group PLC Announces Retirement of Andrew Lewis as DirectorChemring Group PLC announced that After six years as a director of the Company, Andrew Lewis has informed the Board of his intention to retire. Andrew's notice period is 12 months; he will continue in role to ensure a smooth transition. The Board has commenced a search process to identify his successor.
お知らせ • Dec 13Chemring Group PLC, Annual General Meeting, Mar 15, 2023Chemring Group PLC, Annual General Meeting, Mar 15, 2023.